Agreement offers exclusive rights to commercialize six products in key areas of anti-infectives and oncology.Products from Adalvo slated for near- to mid-term launches, with four out of six anticipated to be first-to-marketSandoz continues to expand patient access to much-needed medications,…
Source: www.novartis.com – Read more
Group-IB’s Threat Intelligence and Defence Centre Equip Undergraduates with Sophisticated Cybersecurity Technologies to Boost Threat Analysis and Enhance Cyber Resilience for Campus Start-ups
Hey there from the heart of the San Francisco Bay Area! It’s an absolute pleasure to have you back again for our chat on some
